Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-023014

President and CEO sold 21,920 shares at $3.70 ($81,128)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
AUERBACH ALAN H President and CEO 2024-07-17 Sale 10b5-1 −21,920 $3.70 $81,128 7,063,515 D
Open-market sales · 21,920 sh · avg $3.70 · $81,128
Loading xslF345X05/rdgdoc.xml…